ResearchMoz added Latest Research Report titled ” Global H1N1 Vaccines Market 2016-2020 ” to it’s Large Report database.
About the H1N1 Vaccines Market
The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi’s VaxiGrip, VaxInnate’s VAX2012Q, and AstraZeneca’s MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=741705
Technavios analysts forecast the global H1N1 vaccines market to grow at a CAGR of 4.17% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global H1N1 vaccines market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of vaccines used to prevent H1N1 infection. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.
The market is divided into the following segments based on geography:
Read All healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
Key market highlights
PART 05: Disease overview
Understanding the disease
Causes of H1N1 diseases
Signs and symptoms
PART 06: Regulatory scenario of vaccines
PART 07: WHO recommendations for H1N1 vaccines
Key H1N1 virus vaccines for 2014-2015 season in US
H1N1 virus vaccines approved in EU
PART 08: Reimbursement for influenza vaccines in US
The US healthcare reform
Reimbursement for influenza vaccines
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/